For years, we have told women to get their mammograms. We have wrapped buildings in pink lights. We have filled October with ribbons, walks, campaigns, commercials, survivor stories, and reminders. We have created an entire cultural season around breast cancer awareness. And still, millions of women do not get screened on time.
At some point, we have to ask a more uncomfortable question: What if awareness was never the real problem?
As a breast imaging radiologist, I have spent my career watching the system explain missed screening with one word: noncompliance. It is a clean word. A clinical word. A word that places the failure neatly on the patient. She did not comply. She did not follow through. She did not prioritize her health.
But after years of building a mobile mammography company and bringing breast imaging directly to women at workplaces, schools, community centers, and underserved areas, I have become convinced that this word is not only inadequate. It is often wrong.
Real physician voices, twice a week
Free, and one click to unsubscribe.
Missing a mammogram is usually not a compliance issue. It is a convenience issue. And it is worse than we think.
The statistics can make the problem look smaller than it is. The U.S. Preventive Services Task Force now recommends biennial screening mammography for women ages 40 to 74, a major change from the prior framework that began routine screening at 50. The Healthcare Effectiveness Data and Information Set (HEDIS), one of the most widely used health care quality measurement systems, has also updated its breast cancer screening measure for measurement year 2025, expanding the age range from 50-74 to 40-74. But the measure still generally asks whether a woman had a mammogram within a roughly two-year window, not whether she receives truly annual screening. That distinction matters.
A woman who gets one mammogram every 27 months may look “compliant” on a quality dashboard. But in real life, breast cancers do not wait for measurement windows. Time matters. Tumors grow. Nodes become involved. Stage migration happens. The difference between early detection and delayed detection can be the difference between a lumpectomy and chemotherapy, between a treatable cancer and a metastatic one, between life interrupted and life lost.
Even the national screening numbers are more sobering than the public narrative suggests. CDC data show that mammography use within the previous two years was 59.1 percent among women ages 40-49 and 76.5 percent among women ages 50-74 in 2022. The CDC’s FastStats page reports 62.1 percent for women ages 40-49 and 80.0 percent for women ages 50-74 within the past two years using 2023 data. Those are two-year numbers, not annual numbers, and they do not erase the persistent gaps among women with fewer resources, less flexible work schedules, transportation barriers, or no insurance.
So when we talk about “compliance,” we should be honest about what we are measuring. We are not always measuring optimal prevention. Sometimes we are measuring whether a woman managed to navigate a health care system that was never designed around her life.
Most health care delivery was built for sick people
That sounds obvious, but it is one of the most important truths in American medicine. Hospitals and imaging centers were originally designed around diagnosis and treatment. A patient develops symptoms. A physician orders a test. The patient enters the system because something is wrong.
That model makes sense when someone is ill. If you cannot breathe, you will sit through the intake process. If you have severe abdominal pain, you will wait in the emergency department. If you feel a lump, you will rearrange your day.
But screening is different.
Screening asks healthy people, with no symptoms, no pain, and no immediate crisis, to interrupt their lives for a future possibility. It asks a woman to leave work, find child care, drive across town, park, fill out forms, wait, undergo the exam, return to work, and then hope the bill is what she was told it would be. And when she does not do that perfectly, we call her noncompliant. That is backwards.
Imagine a school where half the class fails the same test year after year. At first, maybe we blame the students. They did not study. They did not care. They did not try hard enough. But if half the class keeps failing, year after year, at some point a serious educator asks whether the teaching method is broken.
Health care rarely asks that question.
Instead, we built a system that is hard to access and then created a vocabulary that blames patients for not accessing it. That vocabulary protects the system from self-examination. It lets us say, “She didn’t get her mammogram,” instead of, “We made the mammogram too hard to get.” It lets us say, “Patients need more education,” when many patients already know exactly what they are supposed to do. They simply cannot afford to lose half a day of work. They cannot get through the phone tree. They cannot wait months for an appointment. They cannot risk a surprise bill. They cannot make preventive care fit inside a life that is already stretched to the breaking point.
Awareness is not access. A pink ribbon is not an appointment. A reminder letter is not a ride, child care, paid time off, transparent pricing, same-day results, or a system that respects the fact that the patient is healthy and busy.
Why mobile mammography matters
This is why mobile mammography matters. But even that statement requires nuance.
Mobile mammography is not automatically patient-centered. A mammography bus parked in a community is only one part of the answer. If the process is confusing, if results are delayed, if patients cannot easily understand their next steps, if dense breast tissue leads to another appointment weeks later, if the billing is unclear, if the schedule serves the provider more than the patient, then mobility has solved only the geography problem.
True patient-centered screening is bigger than location. It means bringing care to where women already are. It means same-day results whenever possible. It means clear pricing before the exam, not after. It means direct access to reports. It means designing workflows around the reality that a woman may have 20 minutes between meetings, a lunch break at a school, or one narrow window before picking up her children. It means treating convenience not as a luxury, but as a clinical intervention.
That last point is important. Convenience is often dismissed in medicine as a consumer preference, something soft or secondary. But in screening, convenience is not cosmetic. It is causal. Convenience determines whether prevention happens.
If the test does not happen, the cancer is not found early. If the cancer is not found early, the patient may need more aggressive treatment. If the diagnosis is delayed long enough, the outcome may change forever. In that sense, convenience is not separate from quality. Convenience is quality.
The next great leap in cancer screening
We have spent decades improving the technology of breast imaging. Digital mammography. 3D tomosynthesis. Artificial intelligence. Risk models. Better biopsy devices. Better treatment. Better systemic therapy. All of that matters. But a perfect mammography machine cannot help a woman who never reaches it.
The next great leap in cancer screening may not come only from a new device or drug. It may come from redesigning the delivery system so that prevention is easy enough to actually happen. That requires humility from physicians, hospitals, payers, employers, public health leaders, and quality organizations. It requires us to stop mistaking measured compliance for meaningful access. It requires us to ask whether the denominator includes the women most likely to be missed. It requires us to stop celebrating awareness while ignoring friction. And it requires us to retire language that quietly blames patients for system design failures.
Of course, personal responsibility matters. Patients do have agency. Physicians should encourage screening. Public health campaigns have value. But responsibility is not one-sided. If we want women to take preventive care seriously, we have to build a system that takes their lives seriously. A woman should not need unusual persistence to get a mammogram. She should not need a flexible job, reliable transportation, an assertive personality, health literacy, and hours of free time. She should not need to fight the system in order to participate in prevention.
Every year, women die from breast cancers that could have been found earlier. Not all of those deaths are preventable. Biology is real. Aggressive cancers exist. Screening is imperfect. But some delayed diagnoses are not failures of awareness. They are failures of access.
And if we keep calling those failures “noncompliance,” we will keep solving the wrong problem.
The future of breast cancer screening should not be built around scolding women into care. It should be built around bringing care into women’s lives. Less blaming. Less friction. Less pretending that a reminder postcard is a strategy. More access. More transparency. More same-day answers. More systems designed around the patient instead of the institution.
Because missing a mammogram is not always a patient failure. Sometimes it is health care telling on itself.
This essay is cited in the KevinMD record on cancer.
Ryan Polselli is a radiologist.
